Researcher.Life Logo

Therapeutics and Clinical Risk Management : Impact Factor & More

eISSN: 1178-203XpISSN: 1176-6336
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q2Safety Research
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management Journal Specifications

Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutics and Clinical Risk Management ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutics and Clinical Risk Management

Prevention and Care of Pressure Ulcers in Long-Term Bedridden Adult and Older Adult Patients in the Community: A Systematic Review.
  • 1 May 2026
  • Therapeutics and clinical risk management
Outcome of Emergent ABO-Incompatible Liver Transplantation is Acceptable but at the Cost of Higher Diffuse Intrahepatic Biliary Stricture: A Single-Center, Retrospective Study.
  • 1 May 2026
  • Therapeutics and clinical risk management
Comparison of Percutaneous Coronary Intervention Outcomes for in-Stent vs de Novo Chronic Total Occlusions: A Meta-Analysis.
  • 1 Apr 2026
  • Therapeutics and clinical risk management
Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
  • 1 Apr 2026
  • Therapeutics and Clinical Risk Management
Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study.
  • 1 Apr 2026
  • Therapeutics and clinical risk management
Effect of Dexmedetomidine Combined with Esketamine on Postoperative Fatigue in Patients Undergoing Total Laparoscopic Hysterectomy: A Single-Center Randomized Double-Blinded Controlled Trial.
  • 1 Apr 2026
  • Therapeutics and clinical risk management
Prevention and Care of Pressure Ulcers in Long-Term Bedridden Adult and Older Adult Patients in the Community: A Systematic Review.
  • 1 May 2026
  • Therapeutics and clinical risk management
Outcome of Emergent ABO-Incompatible Liver Transplantation is Acceptable but at the Cost of Higher Diffuse Intrahepatic Biliary Stricture: A Single-Center, Retrospective Study.
  • 1 May 2026
  • Therapeutics and clinical risk management
Comparison of Percutaneous Coronary Intervention Outcomes for in-Stent vs de Novo Chronic Total Occlusions: A Meta-Analysis.
  • 1 Apr 2026
  • Therapeutics and clinical risk management
Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
  • 1 Apr 2026
  • Therapeutics and Clinical Risk Management
Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study.
  • 1 Apr 2026
  • Therapeutics and clinical risk management
Effect of Dexmedetomidine Combined with Esketamine on Postoperative Fatigue in Patients Undergoing Total Laparoscopic Hysterectomy: A Single-Center Randomized Double-Blinded Controlled Trial.
  • 1 Apr 2026
  • Therapeutics and clinical risk management

FAQs on Therapeutics and Clinical Risk Management